Evaluation of the effectiveness and impact of BBSRC’s investments in antimicrobial resistance research (PDF)
If you cannot open or read this document, you can ask for a different format.
Request a different format
Email email@example.com, telling us:
- the name of the document
- what format you need
- any assistive technology you use (such as type of screen reader).
Find out about our approach to the accessibility of our website.
Bioscience research has the potential to make a critical contribution to addressing antimicrobial resistance (AMR). The Biotechnology and Biological Sciences Research Council (BBSRC) currently invests approximately £30 million each year across a variety of investment mechanisms.
This document summarises the views and 5 key conclusions of a specialist evaluation panel, who conducted an independent evaluation of the effectiveness and impact of BBSRC’s investments in AMR research.